Life Science REIT PLC (LABS) — Cash Flow-to-Debt Ratio
Life Science REIT PLC (LABS) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of GBX958.00K could theoretically repay 0% of its total liabilities (GBX141.89 Million) in one year. See Life Science REIT PLC (LABS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Life Science REIT PLC Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Life Science REIT PLC across 4 annual periods. Also explore how fast is Life Science REIT PLC growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Life Science REIT PLC (2021–2024)
Year-by-year debt coverage analysis for Life Science REIT PLC. For market capitalisation and broader financial context, see market value of Life Science REIT PLC.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | GBX12.92 Million | GBX138.42 Million | ▲ +55.6% |
| 2023 | 0.06x | GBX7.62 Million | GBX126.96 Million | ▲ +807.7% |
| 2022 | -0.01x | GBX-1.09 Million | GBX128.37 Million | ▼ -102.6% |
| 2021 | 0.33x | GBX3.54 Million | GBX10.82 Million | — |